Sabine Zitzenbacher

Title: **Innovator Spotlight: Sabine Zitzenbacher from Graz, Austria**

Introduction

Sabine Zitzenbacher, an accomplished inventor based in Graz, Austria, has made significant contributions to the field of glycosylation. With a focus on advancing enzyme technology, she has secured a patent that highlights her innovative approach to enhancing sialylation processes. Her work demonstrates the potential for tailored biotechnological applications in various industries.

Latest Patents

Sabine Zitzenbacher holds a patent titled "Quantitative control of sialylation and specific mono-sialylation." This patent details the use of glycosyltransferase variants with N-terminal truncation deletions, which exhibit distinct enzymatic activities. Specifically, her research found that a combination of two variants of human β-galactoside-α-2,6-sialyltransferase I (hST6Gal-I) can catalyze the formation of bi-sialylated and mono-sialylated target molecules under controlled conditions. This advancement allows for quantitative control in sialylation processes of glycoproteins, a crucial aspect in biopharmaceuticals.

Career Highlights

Sabine Zitzenbacher is currently affiliated with Roche Diagnostics Operations, Inc., an industry leader in diagnostic solutions. Her role involves extensive research in glycosylation and enzyme engineering, where she applies her expertise to enhance product efficacy and precision in diagnostics.

Collaborations

Throughout her career, Sabine has collaborated with notable colleagues, including Tibor Czabany and Alfred Engel. These partnerships have fostered a rich exchange of ideas and innovations, contributing to the success of her research initiatives in the field of glycosylation.

Conclusion

Sabine Zitzenbacher exemplifies dedication and ingenuity in the realm of biotechnological innovations. Her patent work not only showcases her skills but also paves the way for future advancements in glycosylation techniques. As she continues her contributions at Roche Diagnostics Operations, Inc., the impact of her research will undoubtedly resonate throughout the scientific community and beyond.